The USFDA has scheduled a Vaccines and Related Biological Products Advisory Committee [VRBPAC] meeting for October 5, 2023. During the meeting, the committee will discuss the Strain Selection for the Influenza Virus Vaccines for the 2024 Southern Hemisphere Influenza Season.
Back to All Events
Earlier Event: October 4
Oncologic Drugs Advisory Committee
Later Event: October 31
Cellular, Tissue, and Gene Therapies Advisory Committee